TrialBMC gastroenterology2021

Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years.

Kazuhiro Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.